Sanofi cannot supply insulin from the Oryol plant to Europe
The French pharmaceutical manufacturer Sanofi cannot fully fulfill its obligations under the special investment contract (SPIC). Due to logistical problems,...
The French pharmaceutical manufacturer Sanofi cannot fully fulfill its obligations under the special investment contract (SPIC). Due to logistical problems,...
The Ministry of Industry and Trade plans to announce a competition for the conclusion of a special investment contract, which...
As Kommersant found out, the Ministry of Industry and Trade approved the application of Rener (part of Rosatom) for a...
The parity joint venture Sollers and the Japanese Isuzu received government approval to terminate the special investment contract (SPIC). In...